Science Explorer Back to mapMap
Institution · Semmelweis University

Most cited papers from Semmelweis University

What are the most cited papers from Semmelweis University?

The most cited paper from Semmelweis University is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction" (7,135) and "Biological properties of extracellular vesicles and their physiological functions" (6,130).

Showing 50 of 60 papers. Every paper with more than 1,342 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
2 Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction John J.V. McMurray et al. · New England Journal of Medicine Open access 19 Sep 2019 7,135
3 Biological properties of extracellular vesicles and their physiological functions María Yáñez‐Mó et al. · Journal of Extracellular Vesicles Open access 2015 6,130
4 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
5 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 6 Mar 2017 5,808
6 Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Milton Packer et al. · New England Journal of Medicine Open access 28 Aug 2020 5,214
7 An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Balázs Győrffy, András Lánczky, Aron Charles Eklund et al. · Breast Cancer Research and Treatment 17 Dec 2009 4,380
8 Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches Joshua A Welsh et al. · Journal of Extracellular Vesicles Open access Feb 2024 4,377
9 A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization Marie‐Claude Morice, Patrick W.J.C. Serruys, José Eduardo Sousa et al. · New England Journal of Medicine Open access 6 Jun 2002 4,047
10 A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing Pablo Landgraf et al. · Cell Open access Jun 2007 3,706
11 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Giuseppe Mancia et al. · Journal of Hypertension Open access 24 Jun 2023 3,385
12 Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein et al. · The Lancet Open access1,458 authors 9 Jun 2019 3,173
13 Prediabetes: a high-risk state for diabetes development Ádám Gyula Tabák, Christian Herder, Wolfgang Rathmann et al. · The Lancet Open access Jun 2012 3,020
14 Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis Dennis M. Black et al. · New England Journal of Medicine Open access 3 May 2007 2,988
15 Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction Scott David Solomon et al. · New England Journal of Medicine Open access 27 Aug 2022 2,863
16 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 22 Jan 2020 2,807
17 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
18 Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles Jan O. Lötvall, Andrew Francis Hill, Fred H. Hochberg et al. · Journal of Extracellular Vesicles Open access 2014 2,741
19 Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma Jeremy Schwartzentruber et al. · Nature 27 Jan 2012 2,736
20 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors 27 Sep 2019 2,699
21 Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments Solomon Hailemariam Tesfaye, Andrew J.M. Boulton, Peter James Dyck et al. · Diabetes Care Open access 28 Sep 2010 2,689
22 Catheter Ablation for Atrial Fibrillation with Heart Failure NASSIR F. MARROUCHE, Johannes Brachmann, Dietrich Andresen et al. · New England Journal of Medicine 31 Jan 2018 2,511
23 Tracking the Evolution of Non–Small-Cell Lung Cancer Mariam Jamal‐Hanjani et al. · New England Journal of Medicine Open access 26 Apr 2017 2,501
24 Initial Invasive or Conservative Strategy for Stable Coronary Disease David Joel Maron et al. · New England Journal of Medicine Open access 30 Mar 2020 2,464
25 Prolactin: Structure, Function, and Regulation of Secretion Marc E. Freeman, Béla Kanyicska, Anna A. Lerant et al. · Physiological Reviews Review 10 Jan 2000 2,460
26 Standardization of sample collection, isolation and analysis methods in extracellular vesicle research Kenneth Whitaker Witwer, Edit I. Buzás, Lynne Bemis et al. · Journal of Extracellular Vesicles Open access 2013 2,457
27 Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom et al. · New England Journal of Medicine Open access 27 Aug 2017 2,456
28 Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Scott David Solomon et al. · New England Journal of Medicine Open access Sep 2019 2,429
29 Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis G Paz-Ares et al. · The Lancet 246 authors 4 Oct 2019 2,310
30 Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles Bence György, Tamás Géza Szabó, Mária Pásztói et al. · Cellular and Molecular Life Sciences Open access 10 May 2011 2,104
31 Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Jonathan Kocarnik et al. · JAMA Oncology Open access601 authors 30 Dec 2021 2,100
32 Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution Christopher Abbosh et al. · Nature Open access104 authors 25 Apr 2017 1,978
33 Genome-wide association study identifies five new schizophrenia loci Stephan Ripke et al. · Nature Genetics Open access196 authors 18 Sep 2011 1,966
34 Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders Fernando Magro, Paolo Gionchetti, Rami Eliakim et al. · Journal of Crohn s and Colitis Open access 2 Feb 2017 1,931
35 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 10 Nov 2022 1,921
36 Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma Dominik Sturm et al. · Cancer Cell Open access Oct 2012 1,881
37 Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation András Lánczky, Balázs Győrffy · Journal of Medical Internet Research Open access 6 May 2021 1,863
38 Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Laurent Peyrin‐Biroulet et al. · The American Journal of Gastroenterology Open access 25 Aug 2015 1,861
39 Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease Brian G. Feagan et al. · New England Journal of Medicine Open access 16 Nov 2016 1,860
40 Suicide prevention strategies revisited: 10-year systematic review Gil Zalsman, Keith E Hawton, Danuta Wasserman et al. · The Lancet Psychiatry ReviewOpen access 11 Jun 2016 1,792
41 Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer Balázs Győrffy · Computational and Structural Biotechnology Journal Open access 2021 1,774
42 Common variants conferring risk of schizophrenia †Genetic Risk and Outcome in Psychosis (GROUP) et al. · Nature Open access Jul 2009 1,723
43 A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes Til Wykes, Vyv C. Huddy, Caroline Cellard et al. · American Journal of Psychiatry Review 15 Mar 2011 1,705
44 ESHRE guideline: endometriosis Christian M. Becker et al. · Human Reproduction Open Open access 2022 1,629
45 Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis Viktória Simon, Pál Czobor, Sára Bálint et al. · The British Journal of Psychiatry Open access 27 Feb 2009 1,610
46 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis Désirée M F M van der Heijde et al. · Annals of the Rheumatic Diseases Open access 13 Jan 2017 1,593
47 Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial Johannes F.E. Mann, Roland Erich Schmieder, Matthew McQueen et al. · The Lancet Aug 2008 1,593
48 Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper Thomas Lener et al. · Journal of Extracellular Vesicles Open access 2015 1,591
49 Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma Antonio Pierangelo Palumbo, Asher Alban Chanan-Khan, Katja Christina Weisel et al. · New England Journal of Medicine Open access 24 Aug 2016 1,535
50 Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets Ádám M. Nagy, András Lánczky, Otília Menyhárt et al. · Scientific Reports Open access 11 Jun 2018 1,472

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.